TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve To consider and approve the unaudited standalone & consolidated financial results for the quarter and half year ended on 30th September 2022 along with the Limited Review Report as provided by the Statutory Auditor of the Company.